Human Cell Line-derived Recombinant Factor VIII (Human-cl-rhFVIII) in Previously Untreated Patients

Clinical trial NCT01712438 · COMPLETED

Trial details

NCT number: NCT01712438
Sponsor: Octapharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Severe Hemophilia A

Start date: 2013-02-01
Primary completion: 2018-12-14
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.